Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowMAX Power Announces Strategic $25 Million Investment by Eric Sprott to Accelerate Commercial Advancement of Canada’s First-Ever Subsurface Natural Hydrogen System
Just nowDLP Resources Announces Closing of Brokered Offering for Gross Proceeds of C$6 Million
Just nowData Storage Corporation Announces Expiration of Public Warrants (NASDAQ: DTSTW)
1m agoMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
2m agoParatus Energy: Invitation to Q1 2026 Earnings Call
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc.

About

3.75USD+0.08 +2.18%
Closed • Updated at 13:14 GMT+00:00
Market Cap$298.67M
P/E Ratio17.18
Volume812.3K
Beta1.10
RSI33.16
Gross Margin64.28%
Health TechnologyPharmaceuticals: Other

Niagen Bioscience, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 8 2026
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
May 6 2026
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
May 4 2026
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
Apr 28 2026
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
Apr 22 2026
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

Community Chat

Ask AI

6ix6ixAIEvents